We have previously reported high ARG1 expression in both circulating GMC and MMC [4, 5], and expansion of ARG1+ GMC in CRC compared to PBC in the present study shows the potential immunosuppressive role of myeloid cells in circulation in CRC patients. Here, ARG1 is linked to colorectal carcinoma.